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The singular mission of West Health, which con-sists of theWest Health Institute, theWest HealthPolicy Center, theWest Health Investment Fund,
nd the West Health Incubator, is to lower the cost of
ealth care. This collective effort was founded by philan-
hropic pioneers Gary and Mary West to create a new,
ower-cost ecosystem enabled by innovative technology
nd solutions. Its independent resources and sole focus
avorably position these organizations to engage all stake-
olders in advancing practical solutions to our nation’s
rowing and unsustainable burden of healthcare costs.
The contributing authors to the papers in this supple-
ent1–12 to the American Journal of Preventive Medicine
offer their perspectives on the roles various stakeholders
play in lowering the cost of health care through preven-
tive medicine, innovation, and technology. Recurring
themes include the need for scientifıc evidence and ad-
herence to the fındings of comparative-effectiveness re-
search, emphasis on prevention and data-driven insights,
increasing price transparency and discussions of value,
improving healthcare productivity, and designing solu-
tions with implementation and scale in mind.
We fınd alignment in the need to (1) change how,
when, what, and by whom healthcare services are deliv-
ered; (2) understand the value of and amount paid for
care prior to receiving that care; (3) incentivize and re-
ward the right care; and (4) govern by effıcient, common-
sense rules. Data are essential to advance these funda-
mental tenets to lower the cost of health care.
The author viewpoints expressed herein support sev-
eral areas that have the potential to favorably impact
healthcare costs:
● Infrastructure Independence®. Providing patients
with the right care, at the right time, wherever they are.
Real-time remote monitoring, actionable diagnostics,
and seamless communication of healthcare informa-
tion all effıciently extend the reach and availability of
clinicians and improve the timeliness and accuracy of
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enabled care coordination, the infrastructure-independent
care model stands in sharp contrast to the current
healthcare delivery system, which is centered on clini-
cian location and availability. Because care is episodic,
it ineffectually addresses chronic diseases, resulting in
exacerbations, clinical decompensations, and compli-
cations that consume enormous amounts of resources.
The infrastructure-independent care model empha-
sizes prevention: primary, secondary, and tertiary. It
relies on data, whose pivotal role is described by
Meier,2 as well as interoperable systems that support
fluid communication. Thismodel demands innovation
that improves healthcare productivity and brings the
needed disruption to enable less expensive profession-
als to provide progressivelymore sophisticated services
in less expensive settings, as espoused by Gottlieb and
Makower.9 Infrastructure independence represents a
technology-driven change in delivery models that can
reduce short- and long-term disease burden. It embod-
ies self-care and growing patient receptivity to receiv-
ing care in settings other than a doctor’s offıce, as
advocated by Sarasohn-Kahn.4 Additionally, infra-
structure-independent care is grounded in data cap-
ture and advanced analytics to optimize decision
making, which are aspects of a prevention-oriented,
learning health system described by Tuckson.6
● Price transparency. Lack of information and the in-
ability to obtain timely, easily accessible, understand-
able, and actionable price data prohibit consumers and
providers from understanding the costs associated
with often routine, sometimes critical, and always eco-
nomically impactful healthcare choices. This situation
makes informed, value-based decision making impos-
sible andoften results in higher-than-necessary costs to
both individuals and the healthcare system.
Managing the personal health ecosystem that Sarasohn-
Kahn4 describes requires online information and tools
that include price data. However, as Shah states,5 al-
though empowering patients with price information is
laudable and imperative, it is unlikely to be suffıcient,
as physicians sign orders and patients often defer med-
ical decisions to their discretion. Physicians can drive a
ground-up approach to cost containment but need to
be privy to costs to do so.
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healthcare resources, including needless repetition
of different elements of clinical care, is wasteful and
unnecessarily costly. Patients and other decision
makers often do not understand the limitations and
capabilities of diagnostic and treatment options,
leading to broadly held but irrational expectations
for care. This lack of understanding, coupled with
the practice of defensive medicine and other per-
verse incentives, drive overuse of medical services
and treatments.
Frakt and Carroll12 provide several examples of
wasteful spending that are counter to comparative-
effectiveness research fındings and the scientifıc ev-
idence base. They state that, to reduce wasteful
spending, we must identify it, disseminate support-
ing data, and overcome the barriers of politics. Shah5
reminds us that physicians and other providers are
essential to optimizing resource decisions. However,
there is a lack of guidance for appropriate bedside
resource management, and we concur with the need
to have an open dialogue on high- and low-value
services. Olchanski and colleagues3 note that there is
a gap in the health economic literature on preventive
care and a need to use comparative-effectiveness
research in combination with intelligent policy de-
sign to drive effective preventive services that im-
prove health outcomes and lower costs. Addition-
ally, the scientifıc evidence base would further
benefıt from more observational data versus clinical
trial extrapolations.
● Practical policy. Fee-for-service payment systems re-
ward doctors and hospitals for driving up the volume
in procedures, rather than rewarding value and better
patient health outcomes. A better approach would be
reimbursement models that incentivize development
and use of equally or more effective low-cost, high-
value alternatives to the status quo.Additionally, effıcient
regulatory pathways that expedite the availability of cost-
effective solutions and reduce the cost of innovation are
needed.
There is broad agreement that healthcare fınancing
warrants reform to nudge all actors in the right direc-
tion. Straube8 advocates that the government should
focus on prevention and health promotion and high-
lights recent activities to support that aim. He encour-
ages leveraging Medicare coverage decisions to guide
and influence the rest of the market. Isaac7 shares in-
sight on the favorable long-term impact of effective
wellness programs and aligned incentives, including
lower costs, fewer days lost to disability, and lower
employee turnover. Senior Community Centers of San
Diego, as described by Pettigrew,10 is an outcomes-based model for providing cost-effective preventive
care by holistically addressing the needs of low-income
seniors for nutrition, health care, housing, and social
services. Gottlieb and Makower9 caution that the de-
mand for innovations to demonstrate up-front savings
generally fails to capture long-term benefıts and hin-
ders efforts to secure both reimbursement and initial
funding for development.
Regulatory barriers can create an uneven playing
fıeld that favors incumbents at the expense of entrepre-
neurs and their innovations. Regulation adds cost and
may reduce competition by limiting the number of new
products entering the marketplace. In training entre-
preneurs to develop cost-effective innovations, Yazdi11
acknowledges that they must understand how regula-
tory environments affect the potential viability of com-
mercially successful and sustainable solutions.
There are numerous opportunities to lower healthcare
costs. The reality that cost-reduction efforts stand to up-
set the entrenched interests of many stakeholders pres-
ents a challenge. However, there is hope in that stake-
holders recognize the undeniable severity of our
healthcare crisis and the importance of their respective
roles in averting the dire health and economic conse-
quences confronting our nation.
Publication of this article was supported by the West Health
Initiative.
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Did you know?
The AJPM Most Read and Most Cited articles
are listed on our home page.
Go to www.ajpmonline.org.
